Tag: STAT+

January 22, 2026

OpenEvidence Raises $250 Million, Valuation Doubles | STAT

January 22, 2026

Slingshot Pulls Therapy Chatbot Ash Out of UK Over Regulations

January 21, 2026

Congress Deal Avoids Trump Cuts, Boosts HHS Spending

January 20, 2026

Corvus Pill Shows Promise in Eczema Trial

January 20, 2026

Bipartisan Health Care Deal Revived: Congress Reinstates 2024 Agreement

January 19, 2026

Quiet Week in M&A: Why a Slow Period Was a Good Thing

January 19, 2026

FDA Vouchers and Obesity Drug Benefits: What You Need to Know

January 18, 2026

Supreme Court to Review ‘Skinny Labeling’ and Generic Drug Access

January 17, 2026

RFK Dietary Guidelines: Behind-the-Scenes Creation Process

January 17, 2026

NIH Grants Block Senate Budget Talks

January 15, 2026

Lilly & Nordisk Antitrust Lawsuit: Compounder Complaint

January 14, 2026

Obesity Drug Warnings & FDA Approvals: What You Need to Know

January 13, 2026

Day 2 Conference: Gilead News & FDA Response

January 13, 2026

Unitaid Funds Gilead HIV Prevention Drug Access in South Africa & Zambia

January 12, 2026

Investor Noubar Afeyan Warns of Science Backlash in U.S

January 12, 2026

JPM 2026 Biotech: Adam Feuerstein’s Key Advice